Fresh Recalls

FDAClass II · Drug · Recall D-0834-2026 · Recalled September 9, 2026

traZODone Hydrochloride Tablets recall — Teva Pharmaceuticals USA, Inc

Agency report date: September 9, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
traZODone Hydrochloride Tablets
Company / brand
Teva Pharmaceuticals USA
Lot / serial / date codes
Lot: 1394026, Exp. 02/2028.
Distribution
U.S. Nationwide
Agency product description and boundaries

traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of Foreign Tablets/Capsules

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: traZODone Hydrochloride Tablets recall status

3. Open the official notice or contact

Official recall ID
D-0834-2026
Brand
All Teva Pharmaceuticals USA recalls
Classification
Class II
Units affected
175,392 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Parsippany, NJ, United States
Firm address
400 Interpace Pkwy Bldg A, N/A, 07054-1120

Identifying details (verbatim from the notice)

Product codes / lots
Lot: 1394026, Exp. 02/2028.
Distribution
U.S. Nationwide
Firm notified the public via
Letter
FDA event ID
99734
Recall initiated
August 24, 2026
FDA classified
September 8, 2026
FDA report date
September 9, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page